search
Back to results

Efficacy Testing of a Culturally Relevant Stigma Intervention With WLWH in Tanzania

Primary Purpose

HIV, Stigma, Social, Self Efficacy

Status
Recruiting
Phase
Not Applicable
Locations
Tanzania
Study Type
Interventional
Intervention
Labda Siku Moja stigma reduction intervention
Sponsored by
Duke University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for HIV focused on measuring HIV, women living with HIV, clinical trial, Tanzania, efficacy, feasibility

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

The inclusion criteria for this study are:

  • (1) women who are living with HIV;
  • (2) age 18 (age of adulthood as defined by the Tanzanian government);
  • (3) able and willing to voluntarily consent to participate in the study;
  • (4) able to travel to a data collection in their local community (as described above);
  • (5) demonstrate mental competence at time of informed consent;
  • (6) verbally indicate that they plan to reside in their current community for at least 6 months after enrollment (necessary to prevent attrition);
  • (7) score at the median or higher level on the Swahili Version of the Multidimensional Measure of Internalized HIV Stigma Scale.

Exclusion Criteria:

  • (1) any acute psychological or physiological distress; if there is evidence of acute psychologic and/or physiologic, they will be excluded from this study and referred to an appropriate site for evaluation and treatment.
  • (2) Transgender women living with HIV will not be eligible to participate in this study to reduce the potential for confounding sources of stigma recognizing that a transgender identity is highly stigmatized and culturally sensitive in Tanzania. Further, it would be exceedingly difficult to recruit a sufficient sample of transgender women living with HIV to conduct an appropriate analysis.
  • (3) Participants may be enrolled in other HIV-related studies except cognitive-behavioral intervention studies addressing stigma, self-efficacy, self-esteem, and/or disclosure

Sites / Locations

  • Muhimbili University of Health and Allied SciencesRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Treatment as Usual Group

Stigma Intervention Group

Arm Description

This group will receive treatment as usual which means that no formal stigma reduction intervention will be provided. At the end of the follow-up period, this group will be invited to view the Labda Siku Moja stigma reduction intervention without follow-up.

This group will participate in a 5 week intervention. Each week, intervention group participants will watch one ethnodrama segment of the Labda Siku Moja stigma reduction intervention followed by a guided debrief using motivational interviewing.

Outcomes

Primary Outcome Measures

Number of participants recruited as measured by enrollment logs
Number of study participants retained in study as measured by enrollment logs
Percent of questions left blank on study instruments
Number of women who completed all 5 sessions

Secondary Outcome Measures

change in internalized stigma, as measured by the Swahili version of the Multidimensional Measure of Internalized Stigma Scale
Scores range from 0 to 100 with lower scores indicating less stigma and higher scores indicating more stigma
change in coping self-efficacy, as measured by the Swahili version of the Coping Self-Efficacy Scale
Scores range from 0 to 26, with lower scores indicating lower coping self-efficacy and higher scores indicating greater coping self-efficacy.
change in self-esteem, as measured by the Swahili version of the Rosenberg Self-Esteem Scale
Scores range from 10 to 40, with lower scores indicating lower self-esteem and higher scores indicating higher self-esteem
change in hope, as measured by the Swahili version of the State of Hope Scale
Scores range from 6 to 24, with lower scores indicating less hope and higher scores indicating more hope
change in depressive symptoms, as measured by the Swahili version of the Patient Health Questionnaire 9
Scores range from 0 to 27, with lower scores indicating less depressive symptoms and higher scores indicating more depressive symptoms

Full Information

First Posted
August 31, 2021
Last Updated
October 26, 2022
Sponsor
Duke University
Collaborators
Muhimbili University of Health and Allied Sciences, RTI International
search

1. Study Identification

Unique Protocol Identification Number
NCT05033002
Brief Title
Efficacy Testing of a Culturally Relevant Stigma Intervention With WLWH in Tanzania
Official Title
Efficacy Testing of a Culturally Relevant Stigma Intervention With Women Living With HIV in Tanzania
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 24, 2022 (Actual)
Primary Completion Date
November 2023 (Anticipated)
Study Completion Date
November 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Duke University
Collaborators
Muhimbili University of Health and Allied Sciences, RTI International

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will test a stigma reduction intervention with women living with HIV in Tanzania.
Detailed Description
This study will test a culturally and linguistically relevant stigma reduction intervention, Labda Siku Moja, among women living with HIV in Tanzania.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV, Stigma, Social, Self Efficacy, Self Esteem, Hope, Depressive Symptoms
Keywords
HIV, women living with HIV, clinical trial, Tanzania, efficacy, feasibility

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
160 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Treatment as Usual Group
Arm Type
No Intervention
Arm Description
This group will receive treatment as usual which means that no formal stigma reduction intervention will be provided. At the end of the follow-up period, this group will be invited to view the Labda Siku Moja stigma reduction intervention without follow-up.
Arm Title
Stigma Intervention Group
Arm Type
Experimental
Arm Description
This group will participate in a 5 week intervention. Each week, intervention group participants will watch one ethnodrama segment of the Labda Siku Moja stigma reduction intervention followed by a guided debrief using motivational interviewing.
Intervention Type
Behavioral
Intervention Name(s)
Labda Siku Moja stigma reduction intervention
Intervention Description
The Labda Siku Moja stigma reduction intervention is a tailored stigma reduction intervention for women living with HIV in Tanzania. It is comprised of five ethnodramas (video stories) culturally and linguistically relevant to the Tanzanian women living with HIV.
Primary Outcome Measure Information:
Title
Number of participants recruited as measured by enrollment logs
Time Frame
up to 6 months
Title
Number of study participants retained in study as measured by enrollment logs
Time Frame
up to 180 days
Title
Percent of questions left blank on study instruments
Time Frame
up to 180 days
Title
Number of women who completed all 5 sessions
Time Frame
up to 10 weeks after enrollment
Secondary Outcome Measure Information:
Title
change in internalized stigma, as measured by the Swahili version of the Multidimensional Measure of Internalized Stigma Scale
Description
Scores range from 0 to 100 with lower scores indicating less stigma and higher scores indicating more stigma
Time Frame
baseline and 30, 90, and 180 days after intervention
Title
change in coping self-efficacy, as measured by the Swahili version of the Coping Self-Efficacy Scale
Description
Scores range from 0 to 26, with lower scores indicating lower coping self-efficacy and higher scores indicating greater coping self-efficacy.
Time Frame
baseline and 30, 90, and 180 days after intervention
Title
change in self-esteem, as measured by the Swahili version of the Rosenberg Self-Esteem Scale
Description
Scores range from 10 to 40, with lower scores indicating lower self-esteem and higher scores indicating higher self-esteem
Time Frame
baseline and 30, 90, and 180 days after intervention
Title
change in hope, as measured by the Swahili version of the State of Hope Scale
Description
Scores range from 6 to 24, with lower scores indicating less hope and higher scores indicating more hope
Time Frame
baseline and 30, 90, and 180 days after intervention
Title
change in depressive symptoms, as measured by the Swahili version of the Patient Health Questionnaire 9
Description
Scores range from 0 to 27, with lower scores indicating less depressive symptoms and higher scores indicating more depressive symptoms
Time Frame
baseline and 30, 90, and 180 days after intervention

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: The inclusion criteria for this study are: (1) women who are living with HIV; (2) age 18 (age of adulthood as defined by the Tanzanian government); (3) able and willing to voluntarily consent to participate in the study; (4) able to travel to a data collection in their local community (as described above); (5) demonstrate mental competence at time of informed consent; (6) verbally indicate that they plan to reside in their current community for at least 6 months after enrollment (necessary to prevent attrition); (7) score at the median or higher level on the Swahili Version of the Multidimensional Measure of Internalized HIV Stigma Scale. Exclusion Criteria: (1) any acute psychological or physiological distress; if there is evidence of acute psychologic and/or physiologic, they will be excluded from this study and referred to an appropriate site for evaluation and treatment. (2) Transgender women living with HIV will not be eligible to participate in this study to reduce the potential for confounding sources of stigma recognizing that a transgender identity is highly stigmatized and culturally sensitive in Tanzania. Further, it would be exceedingly difficult to recruit a sufficient sample of transgender women living with HIV to conduct an appropriate analysis. (3) Participants may be enrolled in other HIV-related studies except cognitive-behavioral intervention studies addressing stigma, self-efficacy, self-esteem, and/or disclosure
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Michael V. Relf, PhD
Phone
919-684-9219
Email
michael.relf@duke.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael V. Relf, PhD
Organizational Affiliation
Duke University School of Nursing
Official's Role
Principal Investigator
Facility Information:
Facility Name
Muhimbili University of Health and Allied Sciences
City
Dar Es Salaam
Country
Tanzania
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mrema Kilonzo, MSc
Phone
+255 022 2150302-6
Ext
2
Email
ihanokilonzo@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Efficacy Testing of a Culturally Relevant Stigma Intervention With WLWH in Tanzania

We'll reach out to this number within 24 hrs